Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article (52)

Advertisement

Research Article Free access | 10.1172/JCI107714

Abnormal Secretion of Insulin and Glucagon by the In Vitro Perfused Pancreas of the Genetically Diabetic Chinese Hamster

Barbara J. Frankel, John E. Gerich, Ryoko Hagura, Rudy E. Fanska, George C. Gerritsen, and Gerold M. Grodsky

Metabolic Research Unit and Department of Medicine, University of California, San Francisco, California 94143

Metabolic Research Unit and Department of Biochemistry, University of California, San Francisco, California 94143

Metabolic Research Unit and Department of Biophysics, University of California, San Francisco, California 94143

Upjohn Company, Kalamazoo, Michigan 49001

Find articles by Frankel, B. in: JCI | PubMed | Google Scholar

Metabolic Research Unit and Department of Medicine, University of California, San Francisco, California 94143

Metabolic Research Unit and Department of Biochemistry, University of California, San Francisco, California 94143

Metabolic Research Unit and Department of Biophysics, University of California, San Francisco, California 94143

Upjohn Company, Kalamazoo, Michigan 49001

Find articles by Gerich, J. in: JCI | PubMed | Google Scholar

Metabolic Research Unit and Department of Medicine, University of California, San Francisco, California 94143

Metabolic Research Unit and Department of Biochemistry, University of California, San Francisco, California 94143

Metabolic Research Unit and Department of Biophysics, University of California, San Francisco, California 94143

Upjohn Company, Kalamazoo, Michigan 49001

Find articles by Hagura, R. in: JCI | PubMed | Google Scholar

Metabolic Research Unit and Department of Medicine, University of California, San Francisco, California 94143

Metabolic Research Unit and Department of Biochemistry, University of California, San Francisco, California 94143

Metabolic Research Unit and Department of Biophysics, University of California, San Francisco, California 94143

Upjohn Company, Kalamazoo, Michigan 49001

Find articles by Fanska, R. in: JCI | PubMed | Google Scholar

Metabolic Research Unit and Department of Medicine, University of California, San Francisco, California 94143

Metabolic Research Unit and Department of Biochemistry, University of California, San Francisco, California 94143

Metabolic Research Unit and Department of Biophysics, University of California, San Francisco, California 94143

Upjohn Company, Kalamazoo, Michigan 49001

Find articles by Gerritsen, G. in: JCI | PubMed | Google Scholar

Metabolic Research Unit and Department of Medicine, University of California, San Francisco, California 94143

Metabolic Research Unit and Department of Biochemistry, University of California, San Francisco, California 94143

Metabolic Research Unit and Department of Biophysics, University of California, San Francisco, California 94143

Upjohn Company, Kalamazoo, Michigan 49001

Find articles by Grodsky, G. in: JCI | PubMed | Google Scholar

Published June 1, 1974 - More info

Published in Volume 53, Issue 6 on June 1, 1974
J Clin Invest. 1974;53(6):1637–1646. https://doi.org/10.1172/JCI107714.
© 1974 The American Society for Clinical Investigation
Published June 1, 1974 - Version history
View PDF
Abstract

Hereditary insulin-deficient diabetes mellitus occurs in certain sublines of nonobese Chinese hamsters. Several characteristics of this syndrome are similar to those seen in insulin-deficient human diabetics. Therefore, to characterize pancreatic islet function, dynamic insulin and glucagon release from normal and nonketotic diabetic hamster pancreases in response to glucose (300 mg/100 ml) and theophylline (10 mM), infused singly and together, was studied in vitro.

20-min glucose infusions of normal hamster pancreases caused biphasic insulin release, consisting of a rapid first peak and a gradually rising second phase, similar to that reported for man in vivo. Both phases were significantly reduced in the diabetic pancreases. Theophylline alone stimulated similar nonphasic insulin release in both the normal and the diabetic pancreases. Glucose and theophylline together caused greater insulin release than either stimulant alone in both normals and diabetics; however, the diabetic response was still subnormal.

Glucose suppressed glucagon release from normal pancreases; suppression was significantly impaired in diabetics. Theophylline stimulated nonphasic glucagon release in both the normals and diabetics. Glucose partially suppressed the theophylline-stimulated release in both groups.

Insulin/glucagon molar ratios of the diabetics were consistently subnormal, although individual hormone levels often overlapped into the normal range.

In summary, the pancreases of genetically diabetic Chinese hamsters perfused in vitro showed: (a) decreased first and second phase insulin release in response to glucose-containing stimuli—only partially ameliorated by theophylline—, and (b) impaired suppression of glucagon in response to glucose, resulting in (c) a decreased insulin/glucagon molar ratio. These data support the suggestion that both alpha and beta cells of diabetic pancreases may be insensitive to glucose.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1637
page 1637
icon of scanned page 1638
page 1638
icon of scanned page 1639
page 1639
icon of scanned page 1640
page 1640
icon of scanned page 1641
page 1641
icon of scanned page 1642
page 1642
icon of scanned page 1643
page 1643
icon of scanned page 1644
page 1644
icon of scanned page 1645
page 1645
icon of scanned page 1646
page 1646
Version history
  • Version 1 (June 1, 1974): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (52)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts